%3Amax_bytes(150000)%3Astrip_icc()%2FTAL-mobile-boarding-pass-AITICKETPRICE0825-0efea14bac794586ab53194bac36dddf.jpg&w=3840&q=100)
AI Is Changing How Airlines Are Pricing Flights—Here's What Travelers Should Know, According to an Expert
Delta shared its plans to use generative AI in an earnings call last month, according to Good Morning America . The airline currently uses the technology to price some domestic flights and hopes to increase it to about 20 percent of its network by the end of the year.
Following the announcement, a trio of senators—Sen. Ruben Gallego, D-Ariz., Sen. Richard Blumenthal, D-Conn., and Sen. Mark Warner, D-Va.—sent a letter to Delta's CEO Ed Bastian voicing concerns the pricing model would lead to privacy issues, "diminish incentives to improve service," and result in higher prices "at a time when American families are already struggling with rising costs."
Delta responded with an open letter saying there was "no fare product Delta has ever used, is testing or plans to use that targets customers with individualized prices based on personal data" and said the company had "zero tolerance for discriminatory or predatory pricing."
However, there are still a lot of questions around what generative AI will actually mean for customers, Katy Nastro, a travel expert for Going, told Travel + Leisure. "This is where the waters get murky and have raised the biggest concern from both lawmakers and consumers alike,' Nastro said.
This is what travelers need to know about AI and Delta's new pricing model.
Delta is working with AI pricing company Fetcherr to develop its new pricing, but Nastro said it may take time. Even when prices are adjusted using this new tech, it might not cause too much of a price fluctuation.
'What both Delta and Fetcherr have expressed is that the AI pricing technology will be more like a super analyst taking into account not just market demand and revenue management. but rather outside forces that can impact demand like the economic climate, weather, seat availability, schedule changes, and more, in real time and exceptionally fast," she said.
But this may not automatically translate into dramatically higher prices. That's because Delta can't raise prices too much higher than other airlines since, at a certain point, even the most loyal Delta customers would look elsewhere.
'The same way your favorite fast-food chain can't charge 50% more than their neighbor with a similar hamburger because hungry customers will go elsewhere, the same thinking applies to airlines,' Nastro said.
We've all been lured in by low prices when trying to book a flight only to discover upcharges during the booking process. Nastro said AI might make carriers even better at it.
'At a certain price point, flyers will buy elsewhere," she said. "But with AI, Delta is betting they can get really good at ... keeping people within their buying ecosystem, even if that means potentially drawing them in with a lower fare to begin with. Think about it, even if they are getting a lower base fare, they have more opportunities to upsell you afterward in a variety of ways.'
Airlines across the United States have adopted models where travelers pay for extras like luggage, seat selection, and other perks depending on the fare they choose. Currently, travelers who fly with Delta's basic economy are not assigned a seat until after they check in for their flight, but are allowed to bring a carry-on bag included in the cost of their ticket.
Delta isn't alone in working with Fetcherr. In fact, Nastro said several major airlines have partnered with the company, including Virgin Atlantic and Mexico's Viva Aerobus. 'When it comes to general AI, airlines are in an AI arms race trying to figure out the best adaptation to give them a slight edge over the competition," she said, adding AI was "the next generation in pricing."
'Price personalization is something airlines have been trying to accomplish for decades,' Nastro added. 'Charge consumers willing or able to pay more, more, while charging those who are sensitive to price, less. Basic economy is a great example of this, by providing a very pared-down offer that will target those looking to pay the least. Imagine that, but with other outside factors all being taken into consideration all at once, every time a traveler goes to buy."
Not necessarily. Nastro said the industry is currently in a wait-and-see period, but added most fares aren't being impacted by AI pricing models. 'Consumers have free will to choose which carrier to fly with, and not all airlines are coming forward and adopting this practice," she said. "American Airlines, for example, publicly highlighted concerns about using AI to dynamically price fares citing it will 'erode trust.''
However, there's not much travelers can do to change their online behavior to protect themselves from getting price gauged because we don't yet know which behavior will impact AI pricing. 'Because this is still very new and a small fraction of the fares listed, it would be extremely difficult to know for certain if there was AI dynamically pricing the flight you were thinking of buying,' Nasto said. 'Some may opt to buy more from online travel agencies or utilize a VPN (though we haven't heard of this shift to either), but for now, it's business as usual until we see this more widely adopted.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Cardinal Health expands urology focus with $1.9bn Solaris Health deal
US drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity Partners. The deal aims to expand the Specialty Alliance, the distributor's multi-speciality management services organisation (MSO) platform, in which Cardinal will gain a stake of around 75%. The acquisition will also create the Urology Alliance, comprising a collaborative network of urology providers within Cardinal's Specialty Alliance MSO, as well as resonate with plans to expand the delivery of urological patient care. Cardinal's Solaris buyout complements its recent acquisitions of Urology America, Potomac Urology, and Academic Urology & Urogynaecology, signalling its urologic strategy. The transaction is expected to be completed by the end of this year, pending customary closing conditions. Cardinal Health CEO Jason Hollar stated that growing the Speciality Alliance is a 'top priority' for the company, with the latest urology purchase leaving it 'well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of the Specialty Alliance, Specialty Networks and Cardinal Health'. Research indicates there is a shortage of urologists in the US, with 62% of US counties lacking a practising urologist and just one new urologist entering the field for every ten retiring. The figures lead to challenges in the broader field, including delayed diagnoses, increased rates of advanced-stage conditions, and significant health disparities, with these particularly pronounced in rural communities. GlobalData's senior medical analyst Selena Yu foresees Cardinal's acquisition as reflecting a shift from drug distribution with a 'lower profit margin, towards higher margin speciality care in urology'. Yu said: 'MSOs help streamline backend work like billing and staffing to allow for physicians to focus on care. 'Additionally, with a large network of specialists, patients can receive care in the same region by different care specialists, which will reduce wait times and improve care continuity. Additionally, the Cardinal Health Alliance has other specialities like oncology specialists, which makes referrals more streamlined.' Cardinal's acquisition coincided with the release of its Q4 2025 financials. The company's profits per share came in at $2.08, beating the forecasted $2.03, yet profits for the quarter came in at $60.2bn, below the $60.92bn forecast, prompting a pre-market stock drop of more than 11% on 12 August. Cardinal's share price has since recovered to a drop of around 6% to $147.05 per share, down from $157.66 per share at market close on 11 August. "Cardinal Health expands urology focus with $1.9bn Solaris Health deal" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Effettua l'accesso per consultare il tuo portafoglio
Yahoo
a minute ago
- Yahoo
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement that the company bribed and illegally induced medical providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound, used for weight loss and diabetes treatment. "Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme," Attorney General Paxton said. The lawsuit builds upon Attorney General's previous legal action to hold drug manufacturers accountable for fraud and abuse, the statement added. Last year, Paxton had sued insulin manufacturers, including Lilly and pharmacy benefit managers (PBMs), alleging that manufacturers artificially raised the prices of insulin and then paid a significant, undisclosed portion back to the PBMs for preferential treatment in return. Eli Lilly did not immediately respond to a Reuters request for comment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a minute ago
- Yahoo
Trump Floats Deal to Let Nvidia's Blackwell Chips Into China -- With a 50% Power Cut
President Donald Trump has signaled he may be open to letting Nvidia (NASDAQ:NVDA) ship a toned-down version of its most advanced Blackwell AI chip to China if the company trims its capabilities by 30% to 50%. The comment comes shortly after Trump confirmed an unusual arrangement already in place for Nvidia's less-powerful H20 chip, which allows exports to China in exchange for a 15% revenue share paid directly to the US government. Advanced Micro Devices will follow the same formula for its MI308 chip, according to a person familiar with the matter. Nvidia has not commented on the president's remarks. Warning! GuruFocus has detected 5 Warning Signs with NVDA. The potential deal for Blackwell would mirror Trump's broader push to secure financial returns for the US in exchange for loosening certain export restrictions a strategy that could influence how American companies negotiate market access in China. While Trump didn't outline a specific timeline, he suggested Nvidia CEO Jensen Huang could soon meet with him to discuss a negatively enhanced Blackwell variant. If approved, the move could mark a shift in how high-end US chip technology is selectively offered abroad. Nvidia's Blackwell chips are the backbone of today's most powerful AI systems but remain off-limits to China under current US rules. Both Nvidia and AMD (NASDAQ:AMD) have taken revenue hits as tighter controls limited exports to older models on par with domestic Chinese alternatives products that have struggled to gain traction. Nvidia has already said it is developing another China-specific chip and will seek approval to sell it. The company noted that further cutting back its Hopper-based H20 chip is no longer viable, suggesting a modified Blackwell could be the clearest path to regaining momentum in one of the world's largest AI markets. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data